OTLK: Outlook Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 115.68
Enterprise Value ($M) 116.08
Book Value ($M) -83.67
Book Value / Share -3.54
Price / Book -1.38
NCAV ($M) -85.15
NCAV / Share -3.60
Price / NCAV -1.36

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -2.91
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.07
Current Ratio 1.07

Balance Sheet (mrq) ($M)
Current Assets 45.62
Assets 47.09
Liabilities 130.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Great Point Partners Llc 9.99 11.23
11-07 13G/A Velan Capital Investment Management LP 3.10 -40.00
04-17 13D/A Syntone Ventures LLC 11.40 -85.99
03-28 13G Tang Capital Partners Lp 9.99
03-20 13D/A GMS Ventures & Investments 37.00 -87.00
01-31 13D/A BioLexis Pte Ltd. 6.40 -14.03

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-02-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-01-24 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2023 ☐TRANSITION REPOR
2023-12-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-27 23,660,574 56,629,305 41.78
2024-11-26 97,509 418,918 23.28
2024-11-25 129,215 545,466 23.69

(click for more detail)

Similar Companies
ONVO – Organovo Holdings, Inc. ORGO – Organogenesis Holdings Inc.
ORMP – Oramed Pharmaceuticals Inc. PALI – Palisade Bio, Inc.
PCSA – Processa Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.